Symbol="ARAV"
AssetType="Common Stock"
Name="Aravive Inc"
Description="Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. The company is headquartered in Houston, Texas."
CIK="1513818"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="LYONDELLBASELL TOWER, 1221 MCKINNEY STREET, SUITE 3200, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="79027000"
EBITDA="-72873000"
PERatio="None"
PEGRatio="None"
BookValue="-0.645"
DividendPerShare="0"
DividendYield="0"
EPS="-2.21"
RevenuePerShareTTM="0.191"
ProfitMargin="0"
OperatingMarginTTM="-7.73"
ReturnOnAssetsTTM="-0.788"
ReturnOnEquityTTM="-385.11"
RevenueTTM="9536000"
GrossProfitTTM="-57801000"
DilutedEPSTTM="-2.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.365"
AnalystTargetPrice="13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.41"
PriceToBookRatio="7.28"
EVToRevenue="9.97"
EVToEBITDA="-1.353"
Beta="2.269"
num_52WeekHigh="2.46"
num_52WeekLow="0.58"
num_50DayMovingAverage="1.55"
num_200DayMovingAverage="1.554"
SharesOutstanding="59869000"
DividendDate="2018-10-16"
ExDividendDate="None"
symbol="ARAV"
open="1.36"
high="1.72"
low="1.35"
price="1.50"
volume="727801.00"
latest_trading_day="2023-07-10"
previous_close="1.32"
change="0.18"
change_percent="13.6364%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="316209"
Change_recent_avg="-0.02"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="503"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="622"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
